Clinical Trial Update: Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating octreotide as palliation for cancer-related bowel obstruction that cannot be removed by surgery; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Colorectal Cancer
• Gastric Cancer
• Gastrointestinal Stromal Tumor
• Ovarian Cancer
• Pancreatic Cancer
• Peritoneal Cancer
• Small Intestine Cancer

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Northwestern University | Conditions: Colorectal Cancer, Constipation, Impaction, and Bowel Obstruction | Phase 2 | Status: COMPLETED